Polysorbate 80 In Swine Flu Vaccines = Infertility

(Organic Health Advisor) – Would you feel comfortable being injected with a vaccine that contains a substance that has been strongly linked to infertility?  Well, if you take the Fluarix swine flu vaccine manufactured by GlaxoSmithKline or any of the other swine flu vaccines that contain Polysorbate 80 that is exactly what you will be doing.  If you are considering getting the swine flu vaccine, or any other vaccine for that matter, perhaps you should educate yourself about EXACTLY what is in these vaccines before you allow them to be injected into your body.

Perhaps you think that linking the swine flu vaccine with infertility is quite a stretch.  Well, let’s take this one step at a time.

#1) Polysorbate 80 is in the Fluarix swine flu vaccine manufactured by GlaxoSmithKline according to the CDC.  This is confirmed by the CDC in the document below…..

http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/excipient-table-2.pdf

#2) A medical study done in Slovakia injected newborn female rats with Tween 80 (Polysorbate 80).  These newborn female rats were injected with Polysorbate 80 at days 4 to 7 after birth.  The researchers found that Polysorbate 80 accelerated the maturation of the female rats, damaged the vagina and womb lining, caused significant hormonal changes, severe ovary deformities and ultimately rendered the young female rats infertile.

In fact, Dee Nicholson, the National Communications Director for Freedom in Canadian Health Care is not shy about saying that Polysorbate 80 is “linked to infertility in mice”.

#3) In the package insert for Fluarix, GlaxoSmithKline specifically mentions that they cannot guarantee that their flu vaccine will not damage your fertility: “FLUARIX has not been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility.”  Thanks to foolishly passed laws by the U.S. government, you will not be able to sue anyone if it does leave you infertile.

#4) GlaxoSmithKline is not alone in using Polysorbate 80.  It is being reported that Novartis is using the adjuvant MF59 in its swine flu vaccine. The MF59 adjuvant contains Tween80 (Polysorbate 80) and squalene among other things.

#5) On the World Intellectual Property Organization, a patent application for a “fertility impairing vaccine”.  The University of Georgia Research Foundation is listed as the patent applicant. 

In the description section of the patent application, Tween 80 (Polysorbate 80) is listed as a preferred ingredient:

“In a preferred embodiment the vaccine comprises oil, preferably a biodegradable oil such as squalene oil, in an amount of about 2.5% to about 15%, preferably about 8% to about 12%. In preparing the vaccine it is advantageous to combine a concentrated oily adjuvant composition with an aqueous solution of the antigen, pZP glycoprotein. Typically, the vaccine is prepared using an adjuvant concentrate which contains lecithin (about 5% to about 15 % wt/vol, preferably about 12% wt/vol) and STDCM (preferably about 25 mg/mL to about 50 mg/mL) in squalene oil. The term % wt/vol means grams per 100 mL of liquid. The aqueous solution containing the isolated pZP glycoprotein is typically a phosphate-buffered saline (PBS) solution, and additionally preferably contains Tween 80 (about 0.2% vol/vol to about 0.8% vol/vol, preferably about 0.4% vol/vol).”

#6) The United Nations is actively seeking ways to limit and control population growth around the globe.  An incredibly shocking U.N. population division policy brief from March 2009 asked this very disturbing question:

What would it take to accelerate fertility decline in the least developed countries?

You can read this almost unbelievable document here:

http://www.un.org/esa/population/publications/UNPD_policybriefs/UNPD_policy_brief1.pdf

The reality is that for the super wealthy global elite and the majority of the social engineers at the United Nations, population control is a major obsession.  If you doubt this fact, just read this article:

http://signsofthelastdays.com/archives/the-radical-population-control-and-eugenics-agenda-of-the-global-elite

The truth is that the more people learn about what is in these vaccines, the less likely they are to take them.  It is important to do your own research before letting anyone inject anything into your body.  Those who blindly trust the government or world health authorities are likely the ones to end up being extremely disappointed in the end.

CDC allegedly falsifies reports–ignoring up to 3,587 Miscarriages from H1N1 Vaccine

Progressive Convergence
Friday, September 17, 2010

A shocking report from the National Coalition of Organized Women (NCOW) presented data from two different sources demonstrating that the 2009/10 H1N1 vaccines contributed to an estimated 1,588 miscarriages and stillbirths.  A corrected estimate may be as high as 3,587 cases.  NCOW also highlights the disturbing fact that the CDC failed to inform their vaccine providers of the incoming data of the reports of suspected H1N1 vaccine related fetal demise.

NCOW collected the data from pregnant women (age 17-45 years) that occurred after they were administered a 2009 A-H1N1 flu vaccine. The raw data is available on the website.

Using the Vaccine Adverse Event Reporting System (VAERS), including updates through July 11, 2010 as a second ascertainment source, capture-recapture statistical methods* were used to estimate the true number of miscarriages and stillbirths following A-H1N1 flu vaccination in the U.S. Typically, even so-called “complete” studies conducted by the CDC have been shown to miss from 10% to 90% of the actual cases because of under-reporting.

The statistical method employed is an expeditious and cost effective method of attempting to ascertain a complete count of all cases when two or more ascertainment sources (VAERS and NCOW survey) have failed to collect all the existing cases. Overall, this approach shows that approximately only 15% of the occurrences of a miscarriage or stillbirth were actually reported.

The corrected estimate for the total number of 2009-A-H1N1-flu-shot-associated miscarriages and stillbirths during the 2009/10-flu season is 1,588 (95% goodness-of-fit confidence interval, 946 to 3587). That is, the lower and upper range-probability of miscarriage and stillbirths due to the H1N1 vaccine was as low as 946 and as high as 3,587.

Eileen Dannemann, Director of NCOW, presented the findings for the second time to Dr. Marie McCormick, chair of the Vaccine Risk and Assessment Working Group, during the Advisory Commission on Childhood Vaccines (ACCV) meeting, Sept 3, 2010. Just prior to Ms. Dannemann’s presentation Dr. McCormick, had pronounced that there were absolutely no H1N1 vaccine-related adverse events in pregnant women in 2009/10, directly contradicting the evidence publicly available. “This baseless and fallacious assessment by the CDC assessment group” says, Dannemann, “has given the green light to the CDC’s Advisory Committee on Immunization Practices (ACIP) to continue their recommendation to give the 2010/11 flu shot to all people, including pregnant women. This upcoming 2010/11 flu vaccine contains the same elements that are implicated in the killing of these fetuses, the H1N1 viral component and the neurotoxin mercury (Thimerosal). Additionally, it contains 2 other viral strains- a 3 in 1 shot for all people”.

The very next week at the Sept 14^th National Vaccine Advisory Committee (NVAC) meeting Dr. McCormick, (despite having been informed on two previous occasions of the VAERS data) pronounced, once again, that there were no adverse events in pregnant women. At the conclusion of the NVAC meeting, during public comment, Dannemann submitted the data for the 3^rd time and concluded with, “Why hasn’t Dr. McCormick looked in the VAERS data base?”  “She looked where she knew she would not find”, a disquieting thought, Ms. Dannemann, said in retrospect.

Excerpts and adaptation from speech delivered by Eileen Dannemann, Director, National Coalition of Organized Women Friday, September 3, 2010 to the Advisory Commission on Childhood Vaccines (ACCV) meeting.

“Initially, at the beginning of the H1N1 pandemic consequence management drill there were allegedly 30 maternal deaths.  It was these deaths that the CDC used as the basis to initiate a strenuous and aggressive campaign to vaccinate the pregnant population with the untested H1N1 vaccine.  The CDC ascertained that there were eventually a total of 56 maternal deaths (assuming the fetuses died with them).  Dr. Alicia Siston’s JAMA study (CDC) acknowledged that most of these deaths were ‘unconfirmed’ H1N1 virus caused deaths despite the fact that the CDC had tests that could have verified, for certain, that these were H1N1 related deaths.

Vaccine-related fetal demise reports from VAERS increased 2,440%–from 7 cases in 2007/8 to 178 in 2009/10. Seventy deaths reported from another source had 7 overlapping cases with VAERS, yielding 241 unique cases.  Simplistically speaking, it would have been 85 to 192 times safer not to vaccinate from the perspective of the in-utero child.

Considering that the total of 56 maternal deaths in Dr. Alicia’s Siston’s study, allegedly due to the H1N1 virus itself, are unverified and in light of the overwhelming adverse events reported, we emphasize that inoculating pregnant women with another untested vaccine containing a combination of components found in the offending 2009 H1N1 vaccine is insupportable. Thus, it must be argued that the CDC was grossly negligent to fail to inform their vaccine providers of the incoming VAERS data, while providers blindly followed the CDC “standard of care” guidelines to vaccinate every pregnant woman in 2009/10.  Furthermore, in the face of these findings and the purposeful withholding of these findings by CDC’s Dr. Marie McCormick and her vaccine risk assessment group, for the CDC’s Advisory Committee on Immunization Practices (ACIP) to recommend another iteration of the same vaccine to pregnant women in 2010/11 may be argued as more than gross negligence -but rather- an act of willful misconduct.

We strongly recommend that the CDC withdraws their continued recommendation to pregnant women, instead, strictly adhering to the FDA/manufacturers warning on the insert packages that the flu shot not be given to pregnant women unless clearly needed.  As well, we suggest that the CDC advise all Ob/Gyns, vaccine providers and the public this year, of last season’s VAERS reports on H1N1 vaccine-related fetal deaths” despite the fact that it may be contrary to CDC’s vaccine uptake performance goals”.

*Gary S. Goldman, Ph.D, author of various peer-reviewed medical journal publications, has verified the capture-recapture

(C-R) figures published in the NCOW report.  Dr. Goldman previously worked for 8 years as a Research Analyst for the L.A. County Department of Health Services in an epidemiological study project funded by the CDC.

H1N1 vaccine liquidation sale now on: Hurry while supplies last!

Natural News

All of a sudden, H1N1 vaccines are available all across America. Walgreens and other pharmacies are pushing the vaccines as if there were an “everything must go” liquidation sale under way. Hurry, get your swine flu vaccine today before everybody figures out they’re useless!

The marketability of vaccines has a strict time limit. They’re only in demand during the fear phase of a pandemic, and that fear phase has long since faded for H1N1. Virtually everyone who wants an H1N1 vaccine has already received one, and the rest of the population is beginning to notice something quite curious: People who got the vaccine are no better off than those who skipped it. In fact, there’s no difference in mortality between those who were vaccinated and those who weren’t, indicating yet again that the swine flu vaccine was a medical hoax to begin with.

If you don’t believe me, just ask the potentially hundreds of thousands of parents who gave their children one of the recently recalled H1N1 children’s vaccines. These vaccines were recalled because they were found to be so weak that they were medically useless. But observant parents are noticing a curious fact: Children who received the “useless” (recalled) vaccine have been no worse off than those who received a full-strength vaccine.

The strength of the vaccine, in fact, appears to be entirely irrelevant to the health outcomes of children. Vaccine or not, strong or weak, children’s reaction to the pandemic has virtually nothing to do with any treatments offered by conventional medicine.

In fact, the greatest determining factor in the health outcomes of children has most likely been their blood levels of vitamin D. But that isn’t tracked by medical professionals… nor even prescribed by them. So we’ll probably never know the exact correlation between vitamin D and H1N1 prevention.

Millions of useless vaccines

So now we have a situation where the U.S. government has spent billions of dollars acquiring H1N1 vaccines that, by the time they were delivered for consumption, were already irrelevant to public health. Does anybody really believe at this point that swine flu is a deadly pandemic that will kill you if you don’t receive a vaccine? You’d have to really look hard to find someone so uninformed (and brainwashed) that they’re making the H1N1 vaccine a priority in their life right now.

So what we’re going to end up with here is a huge stockpile of H1N1 vaccines that nobody wants. Sure, the pharmacies, clinics and hospitals will try to push as many of them as they can (even offering free vaccines sooner or later, just to get people into their stores), but in the end, they’re inevitably going to be sitting on millions of extra doses of vaccine with nowhere to inject them.

There are two solutions for this, from Big Pharma’s point of view:

Strategy #1 – Drum up more fear with the aim that it will boost consumer demand for vaccines. This can be accomplished by getting the mainstream media to highlight the few isolated cases of infants or children dying from H1N1 infections (all of whom are almost certainly vitamin D deficient, again).

Strategy #2 – Mandate mass vaccinations. This is unlikely to happen now that H1N1 appears to have fizzled out. The public won’t go for mandatory shots unless the situation gets a whole lot worse. Of course, Big Government can always force such mandates upon the public, but in the current political climate, such an effort would be met with a backlash of public protest.

So that leaves the last option: Flushing H1N1 vaccines down the drain, and this is exactly what will eventually be done with millions of unsold doses. After all the hype, all the empty promises, all the billions of dollars spent and all the fear mongering, a huge portion of these drugs are just going to be flushed down the toilet, essentially, because that’s how hospitals, pharmacies and even drug makers get rid of excess pharmaceuticals.

Polluting the environment with H1N1 vaccines

There’s a huge environmental concern in all this, of course: What’s the effect of dumping millions of doses of H1N1 DNA / RNA into the public sewer system? No one really knows. It’s yet another grand Big Pharma experiment. And how about the chemical additives, preservatives and adjuncts added to the vaccines? What impact will all those chemicals have on the environment?

It’s a startling fact that the sewage expelled by one city ends up in the public drinking water of the next city downstream. Sewage is treated, of course, to achieve EPA-regulated “safe” status before it’s dumped back into the rivers, but the EPA doesn’t regulate something called “DNA pollution.” DNA and RNA can be dumped into the sewage systems in virtually unlimited quantities, without any regulatory oversight (the FDA doesn’t regulate drug disposal either).

If you think about it, then, this whole swine flu fiasco has been a huge scam of paying money to the drug companies in order to flush swine flu genetic material down the drain. This is the brilliance of government-led health policy, by the way: Spend good money to pollute the planet with potentially dangerous genetic material that might one day end up recombining with some other opportunistic viral candidates circulating in the wild.

What a clever way to help cause the next great pandemic, huh? It’s almost a perfect recipe for vaccine repeat business: Take today’s most virulent pandemic strain, replicate it in pharmaceutical labs around the world, then dump it into the environment for mass distribution. That’s essentially what’s happening here. It sounds insane, but it’s exactly what’s about to take place when the H1N1 liquidation sales are over and medical retailers just start flushing all these vaccines down the drain.

No EPA regulations

There are no EPA regulations that limit the dumping of vaccines directly into the public sewage system, by the way. Dumping excess pharmaceuticals down the drain is routine in modern medicine. Hospitals, clinics, pharmacies and patients routinely flush pharmaceuticals down the drain. This is why you can now find HRT drugs, antidepressants and blood pressure drugs in the fish near any major U.S. city.

So many drugs are now dumped into the sewers that rivers have become Big Pharma runoff zones that poison the fish and destroy aquatic life. No wonder the world’s oceans are dying — they’re all being bathed in Big Pharma’s chemical waste!

But that’s not the end of this story: In places all across America, sewage waste is used to make fertilizer that’s spread on crops. The solid sewage waste is called “biosolids” or “black gold,” and it’s used by farmers and gardeners as a soil additive. What the people using this toxic sludge don’t realize is that it’s contaminated with Big Pharma’s toxic chemicals. And soon, it may be contaminated with H1N1 vaccine material from all the millions of unused doses that pharmacies couldn’t manage to peddle to consumers.

In the end, all those unused vaccines will eventually end up as crop fertilizer. It’s yet another reason to avoid monoculture crops and grow your own food using biodynamic gardening methods, huh?

Harvard MD/Reuters: H1N1 death rate similar to seasonal flu

Reuters
By Maggie Fox, Health and Science Editor

WASHINGTON (Reuters) – The death rate from the pandemic H1N1 swine flu is likely lower than earlier estimates, an expert in infectious diseases said on Wednesday.

New estimates suggest that the death rate compares to a moderate year of seasonal influenza, said Dr Marc Lipsitch of Harvard University.

“It’s mildest in kids. That’s one of the really good pieces of news in this pandemic,” Lipsitch told a meeting of flu experts being held by the U.S. Institute of Medicine.

“Barring any changes in the virus, I think we can say we are in a category 1 pandemic. This has not become clear until fairly recently.”

The Pandemic Severity Index set by the U.S. government has five categories of pandemic, with a category 1 being comparable to a seasonal flu epidemic.

Seasonal flu has a death rate of less than 0.1 percent — but still manages to kill 250,000 to 500,000 people globally every year.

A category 5 pandemic would compare to the 1918 flu pandemic, which had an estimated death rate of 2 percent or more, and would kill tens of million of people.

Lipsitch took information from around the world on how many people had reported they had influenza-like illness, which may or may not actually be influenza; government reports of actual hospitalizations and confirmed deaths.

He came up with a range of mortality from swine flu, from 0.007 percent to 0.045 percent.

Either way, having new information about how many people were infected and did not become severely ill or die makes the pandemic look very mild, he said.

“The news is certainly better than it was in May and even better than it was at the beginning of August,” Lipsitch said.

H1N1 swine flu was declared a pandemic in June after flashing around the world in six weeks. Experts all said a true death rate would not be clear for weeks because it is impossible to test every patient and because people with mild cases may never be diagnosed.

This lack of information made the epidemics in various countries and cities look worse at first than they actually were, Lipsitch said. People sick enough to be hospitalized are almost always tested first.

“Yes, there’s been hype, but I don’t think it’s been an outrageous amount of hype,” Lipsitch said.

Seasonal flu is usually far worse among the elderly, who make up 90 percent of the deaths every year. In contrast, this flu is attacking younger adults and older children, but they are not dying of it at the same rate as the elderly, Lipsitch said.

(Editing by Eric Beech)

US To Buy H1N1 Vaccines From Four Firms

FYI – The standard “aduvant” in flu vaccine is Thimerasol (mercury salts) and the preservative is formaldehyde.

(Updates with amounts of contracts and adds details throughout.)

Nasdaq.com
By Jennifer Corbett Dooren
Of DOW JONES NEWSWIRES

WASHINGTON -(Dow Jones)- The U.S. government signed contracts with four companies worth a total of almost $1 billion to purchase ingredients used to make vaccines against the new H1N1 influenza virus.

Health and Human Services Secretary Kathleen Sebelius said Monday that the department will commit $884 million to purchase supplies of two key ingredients for a potential H1N1 vaccine.

The funds will be used to place additional orders for bulk H1N1 antigen and adjuvant on existing contracts with U.S. units of Sanofi-Aventis SA (SNY) and AstraZeneca Plc (AZN), along with GlaxoSmithKline Plc (GSK) and Novartis AG ( NVS). In May, the government earmarked $1 billion to spend on vaccine development. The bulk of the additional contracts announced Monday goes to Novartis with a contract worth about $690 million. Sanofi’s contract is worth about $61.4 million; Glaxo’s totaled $71.4 million while a contract signed with AstraZeneca’s MedImmune unit totals about $61 million.

Antigen is the active ingredient in a vaccine that causes the human body’s immune system to develop antibodies that help fight an invading virus, HHS said. An adjuvant boosts the body’s response to a vaccine and could potentially reduce the amount of antigen necessary for the body to recognize and fight a virus.

The government said vaccine ingredients will become a part of the pandemic stockpile, for use if a vaccination campaign is necessary. Last week, federal officials said they were planning for a vaccination campaign aimed at school-age children, the age group among the hardest hit by the new virus that was first detected in April. Vaccinating health-care workers would also be a top priority.

Any H1N1 influenza vaccines would be administered separately from seasonal influenza vaccines because production is almost complete for seasonal vaccines.

Vaccine makers are currently developing H1N1 influenza vaccine pilot lots that would be used for tests that are expected to start next month. The Food and Drug Administration is planning a meeting next week to discuss the clinical trials.

The earliest doses of an H1N1 influenza vaccine wouldn’t be available until mid-October and that’s assuming clinical tests show the proposed H1N1 vaccines are safe and likely to be effective.

Federal officials have said they expect tests and the manufacturing process of H1N1 vaccines would be similar to the process for seasonal vaccines. Any H1N1 vaccine campaign would likely be carried out over a several-week period as additional vaccine becomes available. Initially the government is expected to control the vaccine supply and could partner with local health departments and schools to deliver the vaccine.

Separately, a new study of the H1N1 virus published online in the journal Nature Monday suggests the virus is stronger than previously believed. Research led by Yoshihiro Kawaoka of the University of Wisconsin in Madison, showed the H1N1 virus infects the lungs of mice, ferrets and monkeys, making the virus more likely to cause pneumonia compared to seasonal flu, which typically infects cells in the sinuses and throat. Researchers said tests of antiviral drugs in mice showed the drugs worked and suggested the drugs will be effective at combating H1N1 infections in humans.

-By Jennifer Corbett Dooren, Dow Jones Newswires; 202-862-9294; jennifer.corbett@dowjones.com

  (END) Dow Jones Newswires
  07-13-091738ET
  Copyright (c) 2009 Dow Jones & Company, Inc.